Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents?
- 29 February 1996
- journal article
- review article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 48 (2-3) , 155-166
- https://doi.org/10.1016/s0940-2993(96)80036-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Human Relevance of Animal Carcinogenicity StudiesRegulatory Toxicology and Pharmacology, 1995
- Neoplastic Lesions of Questionable Significance to HumansToxicologic Pathology, 1994
- Rodent Carcinogenicity Bioassay: Past, Present, and FutureToxicologic Pathology, 1994
- The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposuresMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Detection of human carcinogensNature, 1991
- Determination of the genotoxic status of a chemicalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTPMutation Research/Reviews in Genetic Toxicology, 1991
- Too Many Rodent Carcinogens: Mitogenesis Increases MutagenesisScience, 1990
- The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytesBiochemical Pharmacology, 1990
- Epidemiological Studies of Medically Used DrugsPublished by Springer Nature ,1980